Literature DB >> 15208103

MRI characteristics of olecranon bursitis.

Frank Floemer1, William B Morrison, Georg Bongartz, Hans Peter Ledermann.   

Abstract

OBJECTIVE: Our aim was to describe the MRI characteristics of septic and nonseptic olecranon bursitis.
MATERIALS AND METHODS: MRI contrast-enhanced examinations (n = 19) of 35 patients with olecranon bursitis (septic, n = 14; nonseptic, n = 21) were jointly reviewed by two musculoskeletal radiologists. We evaluated bursa size, extent of marginal lobulation, septation, concomitant elbow joint effusion, soft-tissue edema, rim enhancement, soft-tissue enhancement, degree of fluid complexity, definition of bursa margins, presence of edema, thickening of the triceps tendon, and bone marrow edema.
RESULTS: Comparison of septic and nonseptic bursitis yielded the following results: marginal lobulation, 79% (11/14) versus 48% (10/21), p = 0.14; bursa septation, 64% (9/14) versus 57% (12/21), p = 1.0; moderate or marked complexity of bursa fluid, 64% (9/14) versus 29% (6/21), p = 0.15; poorly defined margins, 64% (9/14) versus 67% (14/21), p = 1.0; elbow joint effusion, 86% (12/14) versus 52% (11/21), p = 0.12; moderate to marked soft-tissue edema, 64% (9/14) versus 33% (7/21), p = 0.1; edema of the triceps, 57% (8/14) versus 48% (10/21), p = 0.73; thickening of the triceps, 43% (6/14) versus 14% (3/21), p = 0.21; bone marrow edema, 29% (4/14) versus 5% (1/21), p = 0.13; rim enhancement, 100% (11/11) versus 75% (6/8), p = 0.31; soft-tissue enhancement, 100% (11/11) versus 63% (5/8), p = 0.1.
CONCLUSION: Septic and nonseptic olecranon bursitis present with a considerable overlap of MRI findings without statistically significant differences. Septic olecranon bursitis can be excluded in the absence of bursal and soft-tissue enhancement.

Entities:  

Mesh:

Year:  2004        PMID: 15208103     DOI: 10.2214/ajr.183.1.1830029

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

Review 1.  Role of Diffusion Weighted Imaging in Musculoskeletal Infections: Current Perspectives.

Authors:  Yogesh Kumar; Mohammad Khaleel; Ethan Boothe; Haitham Awdeh; Vibhor Wadhwa; Avneesh Chhabra
Journal:  Eur Radiol       Date:  2016-05-10       Impact factor: 5.315

Review 2.  Ultrasound evaluation of bursae: anatomy and pathological appearances.

Authors:  Thumanoon Ruangchaijatuporn; Kara Gaetke-Udager; Jon A Jacobson; Corrie M Yablon; Yoav Morag
Journal:  Skeletal Radiol       Date:  2017-02-11       Impact factor: 2.199

Review 3.  Olecranon bursitis: a systematic overview.

Authors:  John R Blackwell; Bruce A Hay; Alexander M Bolt; Stuart M Hay
Journal:  Shoulder Elbow       Date:  2014-05-06

Review 4.  [Treatment of traumatic lesions of the bursa olecrani and chronic bursitis olecrani].

Authors:  D Saul; K Dresing
Journal:  Oper Orthop Traumatol       Date:  2017-06       Impact factor: 1.154

Review 5.  Imaging update on musculoskeletal infections.

Authors:  Teck Yew Chin; Wilfred Cg Peh
Journal:  J Clin Orthop Trauma       Date:  2021-09-16

6.  [Soft-tissue defects following olecranon bursitis. Treatment options for closure].

Authors:  H-G Damert; S Altmann; W Schneider
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

7.  Magnetic resonance imaging of the elbow: a structured approach.

Authors:  Srinath C Sampath; Srihari C Sampath; Miriam A Bredella
Journal:  Sports Health       Date:  2013-01       Impact factor: 3.843

8.  Imaging findings of complications affecting the upper extremity in intravenous drug users: featured cases.

Authors:  Stavroula J Theodorou; Daphne J Theodorou; Donald Resnick
Journal:  Emerg Radiol       Date:  2008-02-26

9.  Imaging of the bursae.

Authors:  Zameer Hirji; Jaspal S Hunjun; Hema N Choudur
Journal:  J Clin Imaging Sci       Date:  2011-05-02

Review 10.  Sonographic assessment of the anatomy and common pathologies of clinically important bursae.

Authors:  Slavcho Ivanoski; Violeta Vasilevska Nikodinovska
Journal:  J Ultrason       Date:  2019-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.